A Thibault1, W D Figg, M R Cooper
1Clinical Pharmacology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892.
Suramin, a drug for parasitic diseases, is being studied for prostate cancer. One patient experienced a severe allergic reaction after the first dose, highlighting the need for vigilance during treatment.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background: